NYSE · Medical Care Facilities · USD
PACS Group, Inc. (PACS) Stock Analysis
PACS Group, Inc. (PACS) is a Medical Care Facilities stock listed on NYSE and quoted in US Dollar.
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
PACS Key Statistics
As of Sep 4, 2026Trading
- Open
- $42.61
- Previous Close
- $43.07
- Day's Range
- 42.11–43.19
- 52-Week Range
- 7.50–49.49
- Volume
- 649.50K
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- −0.13
Valuation
- Market Cap
- $6.73B
- P/E Ratio
- 24.85
- Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
- 15.66
- PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
- 1.09
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 1.21
- EPS (ttm)Profit attributable to each share over the last twelve months.
- 1.71
Financials (FY)
- Revenue (FY)
- $5.29B+29.32%
- Net Income (FY)
- $191.54M+243.51%
- Profit marginThe share of revenue left as profit after all costs and taxes.
- 4.85%
- Shares Outstanding
- 158.34M
- 1-Year Return
- +278.45%
Dividend and dates
- Earnings Date
- November 9, 2026
- Avg Volume
- 874.56K
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
PACS Stock Return by Calendar Year
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | +10.71% |
| 2025 | +192.83% |
| 2024 (partial year) | −43.00% |
As of September 4, 2026.
PACS Revenue and Earnings by Fiscal Year
FY ends December| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $5.29B | $191.54M | 3.6% |
| 2024 | $4.09B | $55.76M | 1.4% |
| 2023 | $3.11B | $112.87M | 3.6% |
| 2022 | $2.42B | $150.50M | 6.2% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $5.29B | $780.33M | $309.60M | $191.54M | 3.6% |
| 2024 | $4.09B | $507.69M | $123.07M | $55.76M | 1.4% |
| 2023 | $3.11B | $447.07M | $207.77M | $112.87M | 3.6% |
| 2022 | $2.42B | $400.68M | $229.36M | $150.50M | 6.2% |
Annual figures as reported, in the company's reporting currency. As of December 31, 2025.
PACS Valuation vs Medical Care Facilities Median
Median of 57 stocks| Metric | PACS | Medical Care Facilities median | vs median |
|---|---|---|---|
| P/E | 24.85 | 19.84 | 25% above |
| P/S ratio | 1.21 | 0.95 | 28% above |
| Profit margin | 4.85% | 3.06% | 1.8 pts above |
Medians across 57 Medical Care Facilities stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.
Recent News
PACS Group Shares Rise 3.3% as Company Plans Florida Expansion and Completes More Eduro Acquisitions
YahooPACS Group to Acquire Operations of 32 Facilities Across Florida and Closes on Additional Previously Announced Eduro Facilities
YahooPACS Group: The Peer Check Stopped Me From Calling It Cheap
SeekingAlphaPACS Group Subsidiaries Enter Into Definitive Agreements To Acquire Operations Of 32 Skilled Nursing Facilities Across Florida; Terms Not Disclosed
BenzingaPACS Group (PACS) Price Target Increased by 14.73% to 60.38
FintelOppenheimer Maintains Outperform on PACS Group, Raises Price Target to $57
Benzinga
All 13 articles ↓Show fewer ↑
UBS Maintains Buy on PACS Group, Raises Price Target to $60
BenzingaRBC Capital Maintains Outperform on PACS Group, Raises Price Target to $57
BenzingaTruist Securities Maintains Buy on PACS Group, Raises Price Target to $62
BenzingaPACS Group, Inc. (PACS) Q2 2026 Earnings Call Transcript
SeekingAlphaPACS Group, Inc. 2026 Q2 - Results - Earnings Call Presentation
SeekingAlphaPACS Group Q2 EPS $0.47 Misses $0.53 Estimate, Sales $1.427B Beat $1.415B Estimate
BenzingaPACS Group Raises FY2026 Sales Guidance from $5.650B-$5.750B to $5.750B-$5.850B vs $5.747B Est
Benzinga
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.
Related Medical Care Facilities Stocks
HCA Healthcare, Inc.
$87.68B
THCTenet Healthcare Corporation
$21.34B
FMSFresenius Medical Care AG
$12.06B
EHCEncompass Health Corporation
$12.01B
DVADaVita Inc.
$11.74B
UHSUniversal Health Services, Inc.
$10.00B
Popular Healthcare Stocks
Eli Lilly and Company
$1.02T
JNJJohnson & Johnson
$663.28B
ABBVAbbVie Inc.
$453.19B
MRKMerck & Co., Inc.
$370.89B
UNHUnitedHealth Group Incorporated
$356.47B










